← Back to Clinical Trials
Recruiting NCT06086873

Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA

Trial Parameters

Condition Dental Implant
Sponsor Barts & The London NHS Trust
Study Type INTERVENTIONAL
Phase N/A
Enrollment 39
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-04-11
Completion 2027-01
Interventions
Implant Type

Brief Summary

This study aims to characterise the stability of crestal bone levels one year after loading, the associated aesthetic outcomes, immunological response, prosthodontic outcomes as well as overall patient reported outcome measures for modSLA (SLActive, Institut Straumann AG, Switzerland) and NGA (TiUltraNP, Nobel Biocare AG, Switzerland) dental implants.

Eligibility Criteria

Inclusion Criteria: * Age: over 18 years old, * Gender: male and female. * Patient must be able and willing to follow study procedures and instructions and have capacity to provide informed consent. * Patient must require tooth extraction of a maxillary first premolar or single-rooted anterior tooth as the result of caries, endodontic failure or trauma * The extraction site must have adjacent teeth present. * Adjacent teeth with no evidence of interdental bone loss Exclusion Criteria: * Systemic disease that can interfere with dental implant therapy (e.g. uncontrolled diabetes) * 2 adjacent teeth requiring extraction * Greater than one wall of the socket missing - assessed at time of extraction * Any contraindications for oral surgical procedures * Any known systemic disease affecting bone metabolism (e.g. Cushing's syndrome, Crohn's disease, rheumatoid arthritis, osteoporosis, diabetes type I and uncontrolled diabetes type II), systemic infections or recent surgical procedures within

Related Trials